Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells.

Dauvois, S

Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells. [electronic resource] - Molecular and cellular endocrinology Oct 1990 - 171-8 p. digital

Publication Type: Journal Article

0303-7207

10.1016/0303-7207(90)90130-z doi


Apolipoproteins
Apolipoproteins D
Breast Neoplasms--pathology
Carrier Proteins
Cell Division--drug effects
Drug Interactions
Estradiol--pharmacology
Flutamide--analogs & derivatives
Gene Expression Regulation, Neoplastic--drug effects
Glycoproteins
Humans
Membrane Transport Proteins
Mifepristone--pharmacology
Neoplasm Proteins--biosynthesis
Promegestone--pharmacology
Tumor Cells, Cultured--drug effects